[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624656":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":38,"centralContacts":56,"locations":63,"responsibleParty":315,"collaborators":38,"id":317,"slug":318,"hasResults":319,"nctId":320,"briefTitle":321,"officialTitle":322,"acronym":323,"eligibilityCriteria":324,"healthyVolunteers":319,"sex":325,"minAge":326,"maxAge":327,"enrollmentInfo":328,"targetDuration":38,"studyType":331,"phases":332,"briefSummary":335,"conditions":336,"keywords":38,"overallStatus":66,"whyStopped":38,"lastUpdateSubmitDate":338,"lastUpdatePostDateStruct":339,"startDateStruct":342,"completionDateStruct":344,"leadSponsor":346,"locationsCount":347},{"fullName":5,"class":6},"Sanofi","INDUSTRY",[8,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Frexalimab","EXPERIMENTAL","The first dose of frexalimab will be given intravenously and subsequent doses of frexalimab will be administered subcutaneously via on-body delivery system(OBDS)",[13,14,15,16,17,18],"Drug: Frexalimab","Drug: rabbit anti-thymocyte globulin","Drug: mycophenolate mofetil","Drug: mycophenolate sodium","Drug: methylprednisolone","Drug: prednisone",{"label":20,"type":21,"description":20,"interventionNames":22},"Tacrolimus","ACTIVE_COMPARATOR",[23,14,15,16,17,18],"Drug: Tacrolimus",[25,31,35,39,42,46,50,53],{"type":26,"name":9,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","Pharmaceutical form:Solution for injection-Route of administration:IV",[9],[30],"SAR441344",{"type":26,"name":9,"description":32,"armGroupLabels":33,"otherNames":34},"Pharmaceutical form:Solution for injection-Route of administration:SC",[9],[30],{"type":26,"name":20,"description":36,"armGroupLabels":37,"otherNames":38},"Pharmaceutical form:Capsule-Route of administration:Oral",[20],null,{"type":26,"name":40,"description":27,"armGroupLabels":41,"otherNames":38},"rabbit anti-thymocyte globulin",[9,20],{"type":26,"name":43,"description":44,"armGroupLabels":45,"otherNames":38},"mycophenolate mofetil","Pharmaceutical form:Tablet or capsule-Route of administration:Oral",[9,20],{"type":26,"name":47,"description":48,"armGroupLabels":49,"otherNames":38},"mycophenolate sodium","Pharmaceutical form:Tablet-Route of administration:Oral",[9,20],{"type":26,"name":51,"description":27,"armGroupLabels":52,"otherNames":38},"methylprednisolone",[9,20],{"type":26,"name":54,"description":48,"armGroupLabels":55,"otherNames":38},"prednisone",[9,20],[57],{"name":58,"role":59,"phone":60,"phoneExt":61,"email":62},"Trial Transparency email recommended (Toll free for US & Canada)","CONTACT","800-633-1610","option 6","Contact-US@sanofi.com",[64,78,88,99,111,121,130,140,152,158,169,178,187,196,205,214,223,232,238,249,260,266,278,285,294,303],{"facility":65,"status":66,"city":67,"state":68,"zip":69,"country":70,"countryCode":71,"cosmosGeoPoint":72,"geoPoint":77,"contacts":38},"Brigham & Women's Hospital- Site Number : 8400049","RECRUITING","Boston","Massachusetts","02115","United States","US",{"type":73,"coordinates":74},"Point",[75,76],-71.05977,42.35843,{"lat":76,"lon":75},{"facility":79,"status":66,"city":80,"state":81,"zip":82,"country":70,"countryCode":71,"cosmosGeoPoint":83,"geoPoint":87,"contacts":38},"Montefiore Medical Center - Moses Campus- Site Number : 8400006","The Bronx","New York","10467",{"type":73,"coordinates":84},[85,86],-73.86641,40.84985,{"lat":86,"lon":85},{"facility":89,"status":66,"city":90,"state":38,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":98,"contacts":38},"Investigational Site Number : 0320001","Corrientes","3400","Argentina","AR",{"type":73,"coordinates":95},[96,97],-58.8344,-27.46784,{"lat":97,"lon":96},{"facility":100,"status":66,"city":101,"state":102,"zip":103,"country":104,"countryCode":105,"cosmosGeoPoint":106,"geoPoint":110,"contacts":38},"Investigational Site Number : 0360002","Adelaide","South Australia","5000","Australia","AU",{"type":73,"coordinates":107},[108,109],138.59863,-34.92866,{"lat":109,"lon":108},{"facility":112,"status":66,"city":113,"state":114,"zip":115,"country":104,"countryCode":105,"cosmosGeoPoint":116,"geoPoint":120,"contacts":38},"Investigational Site Number : 0360001","Parkville","Victoria","3050",{"type":73,"coordinates":117},[118,119],144.95,-37.78333,{"lat":119,"lon":118},{"facility":122,"status":66,"city":123,"state":38,"zip":124,"country":104,"countryCode":105,"cosmosGeoPoint":125,"geoPoint":129,"contacts":38},"Investigational Site Number : 0360003","Sydney","2050",{"type":73,"coordinates":126},[127,128],151.20732,-33.86785,{"lat":128,"lon":127},{"facility":131,"status":66,"city":132,"state":38,"zip":38,"country":133,"countryCode":134,"cosmosGeoPoint":135,"geoPoint":139,"contacts":38},"Investigational Site Number : 0560002","Brussels","Belgium","BE",{"type":73,"coordinates":136},[137,138],4.34878,50.85045,{"lat":138,"lon":137},{"facility":141,"status":66,"city":142,"state":143,"zip":144,"country":145,"countryCode":146,"cosmosGeoPoint":147,"geoPoint":151,"contacts":38},"Investigational Site Number : 1520005","Santiago","Reg Metropolitana de Santiago","8320325","Chile","CL",{"type":73,"coordinates":148},[149,150],-70.64827,-33.45694,{"lat":150,"lon":149},{"facility":153,"status":66,"city":142,"state":143,"zip":154,"country":145,"countryCode":146,"cosmosGeoPoint":155,"geoPoint":157,"contacts":38},"Investigational Site Number : 1520004","8330034",{"type":73,"coordinates":156},[149,150],{"lat":150,"lon":149},{"facility":159,"status":66,"city":160,"state":38,"zip":161,"country":162,"countryCode":163,"cosmosGeoPoint":164,"geoPoint":168,"contacts":38},"Investigational Site Number : 1560003","Chengdu","610041","China","CN",{"type":73,"coordinates":165},[166,167],104.06667,30.66667,{"lat":167,"lon":166},{"facility":170,"status":66,"city":171,"state":38,"zip":172,"country":162,"countryCode":163,"cosmosGeoPoint":173,"geoPoint":177,"contacts":38},"Investigational Site Number : 1560012","Jinan","250014",{"type":73,"coordinates":174},[175,176],116.99722,36.66833,{"lat":176,"lon":175},{"facility":179,"status":66,"city":180,"state":38,"zip":181,"country":162,"countryCode":163,"cosmosGeoPoint":182,"geoPoint":186,"contacts":38},"Investigational Site Number : 1560017","Nanchang","330006",{"type":73,"coordinates":183},[184,185],115.85306,28.68396,{"lat":185,"lon":184},{"facility":188,"status":66,"city":189,"state":38,"zip":190,"country":162,"countryCode":163,"cosmosGeoPoint":191,"geoPoint":195,"contacts":38},"Investigational Site Number : 1560008","Nanning","530007",{"type":73,"coordinates":192},[193,194],108.31667,22.81667,{"lat":194,"lon":193},{"facility":197,"status":66,"city":198,"state":38,"zip":199,"country":162,"countryCode":163,"cosmosGeoPoint":200,"geoPoint":204,"contacts":38},"Investigational Site Number : 1560001","Shanghai","200127",{"type":73,"coordinates":201},[202,203],121.45806,31.22222,{"lat":203,"lon":202},{"facility":206,"status":66,"city":207,"state":38,"zip":208,"country":162,"countryCode":163,"cosmosGeoPoint":209,"geoPoint":213,"contacts":38},"Investigational Site Number : 1560011","Tianjin","300192",{"type":73,"coordinates":210},[211,212],117.17667,39.14222,{"lat":212,"lon":211},{"facility":215,"status":66,"city":216,"state":38,"zip":217,"country":162,"countryCode":163,"cosmosGeoPoint":218,"geoPoint":222,"contacts":38},"Investigational Site Number : 1560006","Wuhan","430030",{"type":73,"coordinates":219},[220,221],114.26667,30.58333,{"lat":221,"lon":220},{"facility":224,"status":66,"city":225,"state":38,"zip":226,"country":162,"countryCode":163,"cosmosGeoPoint":227,"geoPoint":231,"contacts":38},"Investigational Site Number : 1560005","Zhengzhou","450052",{"type":73,"coordinates":228},[229,230],113.64861,34.75778,{"lat":230,"lon":229},{"facility":233,"status":66,"city":225,"state":38,"zip":234,"country":162,"countryCode":163,"cosmosGeoPoint":235,"geoPoint":237,"contacts":38},"Investigational Site Number : 1560009","450061",{"type":73,"coordinates":236},[229,230],{"lat":230,"lon":229},{"facility":239,"status":66,"city":240,"state":38,"zip":241,"country":242,"countryCode":243,"cosmosGeoPoint":244,"geoPoint":248,"contacts":38},"Investigational Site Number : 2080001","Aarhus","8200","Denmark","DK",{"type":73,"coordinates":245},[246,247],10.21076,56.15674,{"lat":247,"lon":246},{"facility":250,"status":66,"city":251,"state":38,"zip":252,"country":253,"countryCode":254,"cosmosGeoPoint":255,"geoPoint":259,"contacts":38},"Investigational Site Number : 3760002","Ramat Gan","5262100","Israel","IL",{"type":73,"coordinates":256},[257,258],34.81065,32.08227,{"lat":258,"lon":257},{"facility":38,"status":66,"city":261,"state":262,"zip":263,"country":264,"countryCode":265,"cosmosGeoPoint":38,"geoPoint":38,"contacts":38},"Torette","Ancona","60020","Italy","IT",{"facility":267,"status":66,"city":268,"state":269,"zip":270,"country":271,"countryCode":272,"cosmosGeoPoint":273,"geoPoint":277,"contacts":38},"Investigational Site Number : 7240001","Barcelona","Barcelona [Barcelona]","08035","Spain","ES",{"type":73,"coordinates":274},[275,276],2.15899,41.38879,{"lat":276,"lon":275},{"facility":279,"status":66,"city":268,"state":280,"zip":281,"country":271,"countryCode":272,"cosmosGeoPoint":282,"geoPoint":284,"contacts":38},"Investigational Site Number : 7240007","Catalunya [Cataluña]","08036",{"type":73,"coordinates":283},[275,276],{"lat":276,"lon":275},{"facility":286,"status":66,"city":287,"state":280,"zip":288,"country":271,"countryCode":272,"cosmosGeoPoint":289,"geoPoint":293,"contacts":38},"Investigational Site Number : 7240003","L'Hospitalet de Llobregat","08907",{"type":73,"coordinates":290},[291,292],2.10028,41.35967,{"lat":292,"lon":291},{"facility":295,"status":66,"city":296,"state":38,"zip":297,"country":271,"countryCode":272,"cosmosGeoPoint":298,"geoPoint":302,"contacts":38},"Investigational Site Number : 7240005","Málaga","29010",{"type":73,"coordinates":299},[300,301],-4.42034,36.72016,{"lat":301,"lon":300},{"facility":304,"status":66,"city":305,"state":306,"zip":307,"country":308,"countryCode":309,"cosmosGeoPoint":310,"geoPoint":314,"contacts":38},"Investigational Site Number : 8260001","Birmingham","England","B15 2TH","United Kingdom","UK",{"type":73,"coordinates":311},[312,313],-1.89983,52.48142,{"lat":313,"lon":312},{"type":316,"investigatorFullName":38,"investigatorTitle":38,"investigatorAffiliation":38,"oldNameTitle":38,"oldOrganization":38},"SPONSOR","100624656","phase-2-a-study-to-investigate-the-efficacy-and-safety-of-frexalimab-versus-tacrolimus-in-adults-undergoing-kidney-transplantation-100624656",false,"NCT07412470","A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation","A Seamless Phase 2\u002F3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients","FREXERA","Inclusion Criteria:\n\n* Participants who are scheduled to receive their first kidney transplant from a living or deceased donor.\n* Participants with low to moderate immunological risk.\n\nExclusion Criteria:\n\n* Deceased donor kidney graft qualified as expanded criteria donor or donor after cardiac death.\n* Positive T or B cell crossmatch, or positive virtual crossmatch per local practice at screening.\n* Participants receiving a kidney graft from HLA-identical living-related donors, or have current or previous solid organ, cell, or multi-organ transplantation, or paired kidney transplantation.\n* Participants whose primary causes of ESKD are idiopathic FSGS, C3 glomerulopathy, lupus nephritis, or thrombotic microangiopathy\n* Evidence of active or latent TB, HIV, HBV or HCV infection.\n* Participants who have known genetically predisposed thrombophilia, have history of thromboembolic events, or who need long-term anti-coagulation therapy.\n* Participants who have severe medical co-morbidities, active infection, or severely limited life expectancy due to underlying medical conditions that are generally precluded from kidney transplant.\n\nThe above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.","ALL","18 Years","70 Years",{"count":329,"type":330},526,"ESTIMATED","INTERVENTIONAL",[333,334],"PHASE2","PHASE3","The purpose of this open-label, randomized, active-comparator-controlled study is to determine the efficacy and safety of frexalimab subcutaneous administrations up to 5 years compared to tacrolimus capsules in adults undergoing kidney transplantation. Participants aged 18 to 70 years who have low-to-moderate immunologic risk of graft rejection and receive their first kidney transplant are eligible if they meet all inclusion and no exclusion criteria. Study details include:\n\n* The study and treatment duration will be up to approximately 5 years.\n* The number of visits will be approximately 38.",[337],"Kidney Transplant Rejection","2026-06-18",{"date":340,"type":341},"2026-06-23","ACTUAL",{"date":343,"type":341},"2026-03-13",{"date":345,"type":330},"2033-08-15",{"name":5,"class":6},26]